Back to trial details

Intake questionnaire

A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)

Applying to Houston Methodist Hospital - Houston Methodist Neal Cancer Center ( Site 0113) · Houston, Texas

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Small Cell Lung Cancer Extensive Stage?
3. Are you able to travel to Houston for study visits?